Treatment of Chronic Mucocutaneous Candidiasis

Letters1 March 1977Treatment of Chronic Mucocutaneous CandidiasisRICHARD H. MEADE III, M.D.RICHARD H. MEADE III, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-86-3-314 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptChronic mucocutaneous candidiasis has been exceedingly difficult to treat. The methods reported have had varied success. Transfer factor was effective in the treatment of one anergic girl but failed in the therapy of seven others (1, 2). Amphotericin B has not been more than temporarily effective (3). Thyroid replacement was effective in a boy with myxedema (4). Clotrimazole was so effective in one patient after all other available measures had failed that it is presented here for the consideration of others.The patient, a woman of 40 anergic to mumps,Candida, and to 250 U...References1. PABSTSWANSON HR: Immunotherapy in candidiasis. Lancet 1:1022, 1972 CrossrefMedlineGoogle Scholar2. LEVINSPITLERFUDENBERG ALH: Transfer factor therapy in immune deficiency states. Annu Rev Med 24:175-208, 1973 CrossrefMedlineGoogle Scholar3. MONTESPITTMANMOORE LCW: Chronic mucocutaneous candidiasis. Influence of thyroid status. JAMA 221:156-159, 1972 CrossrefMedlineGoogle Scholar4. MARMORBARNETT ME: Cutaneous anergy without systemic disease. Am J Med 44:979-989, 1968 CrossrefMedlineGoogle Scholar5. HOLTNEWMAN RR: Laboratory assessment of the antimycotic drug clotrimazole. J Clin Pathol 25:1089-1097, 1972 CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byClotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studiesOral complications in patients with advanced cancerOral Complications in Patients with Advanced CancerChronic mucocutaneous candidosis in monozygotic twinsImmunodeficiency Syndromes and the GutChronic mucocutaneous candidiasisChronic Mucocutaneous CandidiasisA new approach to the use of antifungal agents in infants with persistent oral candidiasisSuccessful treatment of chronic mucocutaneous candidiasis with ketoconazoleResistance to Gonorrhea Possibly Mediated by the Genital Microbial FloraChronic mucocutaneous candidiasis.Topical clotrimazole treatment of chronic mucocutaneous candidiasisTreatment of Chronic Oral Candidiasis with Clotrimazole TrochesSevere Candidal Infections Clinical Perspective, Immune Defense Mechanisms, and Current Concepts of TherapyJOHN E. EDWARDS Jr., M.D., ROBERT I. LEHRER, M.D., E. RICHARD STIEHM, M.D., THOMAS J. FISCHER, M.D., LOWELL S. YOUNG, M.D., F.A.C.P. 1 March 1977Volume 86, Issue 3Page: 314-315KeywordsAmphotericinCandidaCandidiasisMumpsThyroid Issue Published: 1 March 1977 PDF downloadLoading ...